SCHEMBL13613303

SCHEMBL13613303

O=C(O)NNP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440477 0.74
SCHEMBL9251526 0.70
Ammonia Solution, Strong SCHEMBL10981538 0.70 CA1 (0.36)
SCHEMBL1982750 0.67
SCHEMBL11592669 0.64 ALDH1A1 (0.33)
SCHEMBL844671 0.61
SCHEMBL10631417 0.61
SCHEMBL1843274 0.61
SCHEMBL1768123 0.61
Hydrochloric Acid SCHEMBL3711208 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014034719-A1 QUINOLINE DERIVATIVE HAVING TLR INHIBITORY ACTIVITY 興和株式会社 (JP) 2014-03-06 WO disclosed
US-20090298845-A1 PIPERAZINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY 2009-12-03 US disclosed
US-7615556-B2 Piperazinyl derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2009-11-10 US disclosed
US-20070179148-A1 PIPERAZINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY 2007-08-02 US disclosed